Common use
Septilin tablet is a unique formulation with immunomodulatory, antioxidant, anti-inflammatory and antimicrobial properties that help maintain general health and wellbeing. It helps boost immunity and improve the body's resistance to infections.
Dosage and direction
The typical dosage of Septiline is 1-2 tablets twice daily, preferably after meals. Septiline can be used for several weeks to a few months, depending on the condition being treated. For chronic conditions, it may take longer to see noticeable improvements.
Precautions
As with all supplements, it’s important to consult with a doctor or healthcare provider before starting Septiline, especially if you have per-existing conditions or are taking other medications.
Contraindications
Food supplements should not be used as a substitute for a balanced and varied diet and a healthy lifestyle. Do not exceed the recommended daily dose.
Not recommended for children under 4 years of age. Avoid in pregnant or breastfeeding women.
Possible side effect
Septiline is generally considered safe when used as directed, but some individuals may experience mild side effects, including: Mild Digestive Discomfort: Some people may experience mild nausea, bloating, or gas, especially if they have a sensitive digestive system; Allergic Reactions: In rare cases, people may be allergic to one of the ingredients. Symptoms of an allergic reaction may include rashes, itching, or swelling.
Drug interaction
Other drugs may interact with Septilin, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.
Missed dose
If you miss a dose of Septilin, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Overdose
Seek emergency medical attention.
Storage
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
